Real-time enrollment status for this cancer clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 12:03 PM UTC
| NCT Number | NCT04094610 |
| Recruiting Status | Recruiting |
| Condition | Cancer |
| Phase | PHASE1 |
| Target Enrollment | 75 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Turning Point Therapeutics, Inc. |
| Last Updated on CT.gov | September 25, 2026 (2 weeks ago) |
As of October 13, 2026: Clinical trial NCT04094610 is currently recruiting participants. This phase1 study for cancer is actively seeking new participants at 20 locations across the United States. The study is sponsored by Turning Point Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04094610 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04094610 was last updated 2 weeks ago (September 25, 2026). HelloStudys verifies this status automatically.